Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 158.20% | 409.64% | 380.28% | 402.23% | 100.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 158.20% | 409.64% | 380.28% | 402.23% | 100.78% |
| Cost of Revenue | 212.66% | 814.58% | 627.80% | 517.17% | 64.41% |
| Gross Profit | 110.99% | 229.36% | 245.37% | 319.80% | 148.48% |
| SG&A Expenses | 41.54% | 129.03% | 107.66% | 150.10% | 60.49% |
| Depreciation & Amortization | 126.68% | 113.69% | 61.77% | 19.44% | -59.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.52% | 349.98% | 267.19% | 256.96% | 50.40% |
| Operating Income | 375.40% | 1,438.04% | 653.71% | 351.72% | 203.01% |
| Income Before Tax | 351.39% | 477.93% | 79.15% | 35.20% | -17.40% |
| Income Tax Expenses | 828.21% | 3,458.93% | 1,512.63% | 490.67% | 150.18% |
| Earnings from Continuing Operations | 237.71% | 80.25% | -27.12% | -14.74% | -73.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 237.71% | 80.25% | -27.12% | -14.74% | -73.24% |
| EBIT | 375.40% | 1,438.04% | 653.71% | 351.72% | 203.01% |
| EBITDA | 318.31% | 778.12% | 1,303.13% | 527.50% | 290.93% |
| EPS Basic | 249.03% | 89.36% | -10.19% | 9.85% | -45.14% |
| Normalized Basic EPS | 1,198.28% | 1,149.06% | 346.53% | 197.48% | 121.25% |
| EPS Diluted | 249.03% | 89.36% | -10.19% | 9.85% | -45.14% |
| Normalized Diluted EPS | 1,198.28% | 1,149.06% | 346.53% | 197.48% | 121.25% |
| Average Basic Shares Outstanding | -6.69% | -1.36% | -8.45% | 6.02% | 16.79% |
| Average Diluted Shares Outstanding | -6.69% | -1.36% | -8.45% | 6.02% | 16.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |